Calreticulin Mutation in JAK2V617F Negative Myeloproliferative Neoplasms - The Beaumont Experience

被引：0
作者：
Sikdar, Soma [1 ]
Prada, Anne [1 ]
Crisan, Domnita [1 ]
机构：
[1] William Beaumont Hosp, Royal Oak, MI 48072 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1505
引用
收藏
页码：378A / 378A
页数：1
相关论文
共 50 条
  • [21] Mutation Analysis of Calreticulin in JAK2 V617F-Negative Myeloproliferative Disorders
    Gao, L.
    Stence, A. A.
    Rysgaard, C. D.
    Holman, C. J.
    Bossier, A. D.
    Ma, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06) : 721 - 721
  • [22] Two different myeloproliferative neoplasms due to JAK2V617F mutation of two siblings
    Turgutkaya, A.
    Yavasoglu, I.
    Bolaman, Z.
    Erdogdu, I.
    Bozkurt, G.
    Doger, F.
    LEUKEMIA RESEARCH, 2019, 85 : S55 - S56
  • [23] Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation
    Wenjuan Fan
    Weijie Cao
    Jianxiang Shi
    Fengcai Gao
    Meng Wang
    Linping Xu
    Fang Wang
    Yingmei Li
    Rong Guo
    Zhilei Bian
    Wei Li
    Zhongxing Jiang
    Wang Ma
    Annals of Hematology, 2023, 102 : 1745 - 1759
  • [24] Is the Absence of JAK2V617F Mutation a Risk Factor for Bleeding in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms?
    Ahmed, Shima A.
    Abdallah, Ghada E. M.
    Aly, Mai M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S357 - S357
  • [25] JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan
    Yoko Edahiro
    Soji Morishita
    Kochi Takahashi
    Yumi Hironaka
    Yuriko Yahata
    Yoshitaka Sunami
    Shuichi Shirane
    Miyuki Tsutsui
    Masaaki Noguchi
    Michiaki Koike
    Kiyotoshi Imai
    Keita Kirito
    Naohiro Noda
    Yuji Sekiguchi
    Satoshi Tsuneda
    Akimichi Ohsaka
    Marito Araki
    Norio Komatsu
    International Journal of Hematology, 2014, 99 : 625 - 634
  • [26] JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan
    Edahiro, Yoko
    Morishita, Soji
    Takahashi, Kochi
    Hironaka, Yumi
    Yahata, Yuriko
    Sunami, Yoshitaka
    Shirane, Shuichi
    Tsutsui, Miyuki
    Noguchi, Masaaki
    Koike, Michiaki
    Imai, Kiyotoshi
    Kirito, Keita
    Noda, Naohiro
    Sekiguchi, Yuji
    Tsuneda, Satoshi
    Ohsaka, Akimichi
    Araki, Marito
    Komatsu, Norio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 625 - 634
  • [27] Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
    Yonal-Hindilerden, Ipek
    Daglar-Aday, Aynur
    Akadam-Teker, Basak
    Yilmaz, Ceylan
    Nalcaci, Meliha
    Yavuz, Akif Selim
    Sargin, Deniz
    JOURNAL OF BLOOD MEDICINE, 2015, 6 : 157 - 175
  • [28] Thrombosis in myeloproliferative neoplasia Influence of the mutation JAK2V617F
    Guy, Alexandre
    James, Chloe
    M S-MEDECINE SCIENCES, 2019, 35 (8-9): : 651 - 658
  • [29] Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders
    Marchetti, Marina
    Falanga, Anna
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2007, 36 (3-4) : 148 - 159
  • [30] JAK2V617F mutation detection in myeloproliferative disorders (MPD)
    Bakkus, M. H. C.
    Trullemans, F.
    Demanet, C.
    De Waele, M.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 110 - 110
12345